Long-term Efficacy of Drug-coated Balloon Only Angioplasty for IgG4-related Coronary Artery Disease: a Case Report

Overview

Journal Eur Heart J Case Rep

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2024 Dec 13

PMID 39670284

Authors

Mayu Yamada

Katsumi Ueno

Yoshinobu Kojima

Mitsuru Watanabe

Norihiko Morita

Affiliations

Soon will be listed here.

Abstract

Background: Although coronary artery involvement in patients with IgG4-related disease (IgG4-RD) is rare, emergency revascularization is recommended for managing acute coronary syndrome. However, coronary aneurysm formation and stent migration after sirolimus-eluting stent implantation have been reported for this disease. Thus, new treatment modalities are warranted for the management of coronary artery disease in this vasculitis.

Case Summary: A 70-year-old male who experienced progressive chest discomfort for 1 month underwent cardiac examination. Coronary computed tomography angiography (CCTA) revealed right coronary artery hypoplasia, coronary artery aneurysm with severely calcified stenosis in the proximal left anterior descending artery (LAD), and subtotal obstruction in the mid-LAD. The left circumflex artery (LCX) also had stenosis and dilated lesions. Additionally, diffuse perivascular soft tissue thickening was observed in the mid-LCX. The percutaneous coronary intervention was performed for the proximal- and mid-LAD lesions. Rotational atherectomy with low-pressure drug-coated balloon (DCB) dilation was considered for these lesions owing to suspicion of vasculitis. The patient was later diagnosed with Sjögren's syndrome and IgG4-RD overlap syndrome. Oral steroids and immunosuppressive drugs were initiated. In a follow-up at 7 and 26 months, late lumen enlargement was observed in the treated area of the LAD, without enlargement of the adjacent aneurysm. CCTA performed after 26 months revealed resolution of the diffuse perivascular soft tissue thickening in the mid-LCX.

Discussion: To our knowledge, this is the first case report demonstrating favourable outcomes for treatment of a coronary artery lesion attributed to IgG4-RD with DCB, leaving nothing implanted in the coronary artery tree.

References

Paratz E, Ross L, Zentner D, Morgan N, Bouwer H, Lynch M . Intracoronary IgG4-related disease as an unusual cause of sudden cardiac arrest: a case series. Eur Heart J Case Rep. 2022; 6(2):ytac050. PMC: 8851923. DOI: 10.1093/ehjcr/ytac050. View

Kleber F, Schulz A, Waliszewski M, Hauschild T, Bohm M, Dietz U . Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiol. 2014; 104(3):217-25. DOI: 10.1007/s00392-014-0775-2. View

Ito T, Fukui S, Kanie T, Tamaki H, Okada M . Immunoglobulin G4-related coronary periarteritis: a systematic literature review with a case series. Clin Rheumatol. 2022; 41(8):2281-2295. DOI: 10.1007/s10067-022-06179-y. View

Kubota N, Ozaki K, Hoyano M, Okubo T, Kimura S, Yanagawa T . Improvement of Mass Lesions around Coronary Arteries and Fractional Flow Reserve after Steroid Therapy in Immunoglobulin-G4-related Coronary Periarteritis. Intern Med. 2022; 61(3):351-356. PMC: 8866778. DOI: 10.2169/internalmedicine.7880-21. View

Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K . IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015; 94(15):e680. PMC: 4602507. DOI: 10.1097/MD.0000000000000680. View

Ueno K, Morita N, Kojima Y, Takahashi H, Kawasaki M, Ito R . Safety and Long-Term Efficacy of Drug-Coated Balloon Angioplasty following Rotational Atherectomy for Severely Calcified Coronary Lesions Compared with New Generation Drug-Eluting Stents. J Interv Cardiol. 2019; 2019:9094178. PMC: 6739772. DOI: 10.1155/2019/9094178. View

Shoji K, Wakana N, Zen K, Hori Y, Matoba S . Immunoglobulin G4-Related Coronary Artery Aneurysm-Associated Stent Migration. JACC Case Rep. 2022; 3(18):1895-1897. PMC: 8693308. DOI: 10.1016/j.jaccas.2021.09.001. View

Katz G, Hedgire S, Stone J, Perez-Espina S, Fernandes A, Perugino C . IgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement. Semin Arthritis Rheum. 2023; 60:152184. PMC: 10148901. DOI: 10.1016/j.semarthrit.2023.152184. View

Shiboski C, Shiboski S, Seror R, Criswell L, Labetoulle M, Lietman T . 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2016; 69(1):35-45. PMC: 5650478. DOI: 10.1002/art.39859. View

10.

Ratwatte S, Day M, Ridley L, Fung C, Naoum C, Yiannikas J . Cardiac manifestations of IgG4-related disease: a case series. Eur Heart J Case Rep. 2022; 6(4):ytac153. PMC: 9036079. DOI: 10.1093/ehjcr/ytac153. View

11.

Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G . Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004; 110(7):810-4. DOI: 10.1161/01.CIR.0000138929.71660.E0. View

12.

Tse Y, Lo S, Lau C, Tse H . Regression of IgG4-related coronary arteritis and aortitis with immunosuppressive therapy. Eur Heart J Case Rep. 2022; 6(5):ytac156. PMC: 9071294. DOI: 10.1093/ehjcr/ytac156. View

13.

Ueno K, Morita N, Kojima Y, Takahashi H, Esaki M, Kondo H . Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease. Catheter Cardiovasc Interv. 2023; 101(4):713-721. DOI: 10.1002/ccd.30598. View

14.

Okuyama T, Tanaka T, Nagoshi T, Yoshimura M . Coronary artery disease concomitant with immunoglobulin G4-related disease: a case report and literature review. Eur Heart J Case Rep. 2019; 3(1):ytz013. PMC: 6439393. DOI: 10.1093/ehjcr/ytz013. View